Hepatocellular carcinoma
Conditions
Interventions
None listed
Sponsors
Division of Gastroenterology, Department of Medicine Kurume University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patient who can expect survival more than three months. A case of EOCG performance status 0 or 1. The patient that an effect of the previous treatment, a side effect are not carried over A case (inspection within two weeks before registration) that enough main organ (including marrow, a heart, the liver, the kidney) functions are maintained. More than WBC 2000/mm3 More than 8.5 g/dl of Hb More than Platelet 50,000/mm3 Less than Child-Pugh score seven points Total bilirubin. 2 mg/dl or less There not being the abdominal dropsy that Control is impossible of, hepatic encephalopathy Is less than Creatinine 1.5 mg/dl; or Creatinine Clearance more than 50ml/min Ejection fraction more than 45% (heart trouble merger patient) A PaO2 more than 60 mmHg (chronic lung disease patient)
Exclusion criteria
Exclusion criteria: An infectious disease of the activity (but except the viral hepatitis) An overlap cancer of the activity A past of sensitivity to iodocontrast media A pregnant woman, a nursing girl may be pregnant The case that the medical attendant judged to be inappropriate as an object of the final examination for reasons of others (problem cases such as a patient does not hear instructions or the support of the family not being provided)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is the overall survival time. | — |
Countries
Japan
Contacts
Public ContactMasahito Nakano
Kurume University School of Medicine Division of Gastroenterology, Department of Medicine
Outcome results
None listed